Skip Navigation

Adalvo Recognizes World IP Day 2024: Prioritizing Health and Well-being

Business
26 April 2024

Adalvo acknowledges and participates in World IP Day 2024, joining the global community in celebrating innovation and creativity in intellectual property (IP). This year's theme, "๐ˆ๐ ๐š๐ง๐ ๐ญ๐ก๐ž ๐’๐ƒ๐†๐ฌ: ๐๐ฎ๐ข๐ฅ๐๐ข๐ง๐  ๐จ๐ฎ๐ซ ๐œ๐จ๐ฆ๐ฆ๐จ๐ง ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐ฐ๐ข๐ญ๐ก ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐š๐ง๐ ๐œ๐ซ๐ž๐š๐ญ๐ข๐ฏ๐ข๐ญ๐ฒ," aligns with our declared purpose of making a difference for patients around the world.

Aligning with Sustainable Development Goal 3 (SDG 3) of the 2030 Agenda for Sustainable Development, which aims to ensure healthy lives and promote well-being for all ages, Adalvo recognizes the role of being resourceful and creative in addressing healthcare challenges. ย 

Adalvo's portfolio reflects this commitment, with a range of value-added medicines such as improved formulations like Pregabalin XR and Lisdexamfetamine oral solution, as well as combinations such as Mirabegron + Solifenacin and ย Ambrisentan + Tadalafil. These advancements not only enhance accessibility and affordability but also improve patient adherence, supporting better health outcomes.ย 

As we mark World IP Day 2024, Adalvo reaffirms its dedication to advancing global health through intellectual property and high-quality differentiated solutions.ย ย 

At Adalvo, there are no half-measures - we are always on target. When your mission is to surpass your competitors, you need a dedicated team driving your vision forward.ย 

Partner with us now!ย 

Click Here To Get In Touch!ย